News Sentiment

TEM sentiment intelligence

Tempus AI, Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 76 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 58.23 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

87/100 classification confidence.

Company focus 76

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-3.4% over one week, +21.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 87/100 classification
One-week reaction -3.4% Price reacting lower
Trend fit Trend inactive 21.8% over four weeks
Fair value 1.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 52
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 76
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 10
MarketBeat 8
TradingView 4
Quiver Quantitative 2
DirectorsTalk Interviews 2
The Globe and Mail 2
Business Wire 2

Event Lens

What the news is about

Classified themes
Market update 59
Earnings 11
Analyst action 5
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 76
Stock Titan Direct company coverage

Tempus AI (NASDAQ: TEM) insiders report multi-holder Class A sales

A recent SEC Form 144 filing indicates that several insiders at Tempus AI (NASDAQ: TEM) have reported proposed sales of Class A Common Stock. The filing details multiple transactions from April to May 2026, including sales by Eric Lefkofsky and related entities Blue Media, LLC an

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 22:09
Source
Stock Titan
Investing.com Direct company coverage

Tempus AI CFO James Rogers sells $634,095 in TEM stock

Tempus AI's CFO, James Rogers, sold 11,529 shares of the company's Class A Common Stock for $634,095 on June 25, 2026, as part of a Rule 10b5-1 trading plan. Despite the sale, the stock has seen a 20% return in the past week, though InvestingPro data suggests it may be overvalued

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 08:45
Source
Investing.com
TradingView Direct company coverage

TEM Forecast — Price Target — Prediction for 2027

This article provides a forecast for Tempus AI, Inc. Class A (TEM) stock, including analyst price targets and predictions for 2027. It details the current stock price, recent performance, general market capitalization, and historical highs and lows. The report also addresses comm

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 07:10
Source
TradingView
TradingView Direct company coverage

Tempus AI, Inc. Class A Actuals & Estimates (NASDAQ:TEM)

This article provides an overview of Tempus AI, Inc. (NASDAQ: TEM) stock performance, financial estimates, and analyst forecasts. It includes current stock price, market capitalization, volatility, and details on past earnings reports and upcoming earnings dates. The article also

Tone
Positive 69/100
Event
Earnings
Published
25 Jun 2026 16:09
Source
TradingView
MarketBeat Direct company coverage

Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Brokerages

Tempus AI (NASDAQ:TEM) has received an average "Hold" recommendation from 15 brokerages, with an average 12-month price target of $68.64. The company recently reported Q1 revenue of $348.12 million, beating estimates, and EPS of -$0.13, also surpassing expectations, though it rem

Tone
Neutral 50/100
Event
Earnings
Published
09 Jun 2026 07:10
Source
MarketBeat
MarketBeat Direct company coverage

Alethea Capital Management LLC Makes New Investment in Tempus AI, Inc. $TEM

Alethea Capital Management LLC has made a new investment in Tempus AI, Inc. (NASDAQ:TEM), purchasing over 31,500 shares worth approximately $1.86 million, making it the 7th largest holding in their portfolio. This comes despite significant insider selling from Tempus AI executive

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 07:10
Source
MarketBeat
TradingView Direct company coverage

Tempus AI, Inc. Class A Trade Ideas — XETR:F3M

This article provides trade ideas and technical analysis for Tempus AI, Inc. (XETR:F3M), focusing on key support and resistance levels. It outlines bullish and bearish scenarios based on price movements around 76.60 (support) and 77.30 (resistance), noting a double top pattern in

Tone
Positive 66/100
Event
Market update
Published
07 Jun 2026 06:10
Source
TradingView
MarketBeat Direct company coverage

Tempus AI (NASDAQ:TEM) Trading Up 9.3% - Time to Buy?

Tempus AI (NASDAQ:TEM) saw its shares rise 9.3% in mid-day trading, though with lower-than-average volume. The company recently beat earnings expectations with a smaller loss and significant revenue growth, despite still operating with negative margins. Analyst ratings are mixed,

Tone
Positive 65/100
Event
Earnings
Published
04 Jun 2026 21:10
Source
MarketBeat
Stock Titan Direct company coverage

Tempus AI (TEM) director Epstein sells 250 shares in pre-planned trade

David R. Epstein, a director at Tempus AI (TEM), sold 250 shares of Class A Common Stock at $49.40 per share under a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024. Following this transaction, Epstein directly holds 31,464 shares. The sale is considered routine

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 20:09
Source
Stock Titan
Market source Direct company coverage

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

Tempus AI, Inc. announced the launch of an open-source digital pathology IMS Consortium with Yale New Haven Hospital and Memorial Sloan Kettering Cancer Center as founding academic members. The consortium aims to democratize and standardize digital pathology by developing an open

Tone
Positive 73/100
Event
Market update
Published
03 Jun 2026 12:30
Source
Market source
The Globe and Mail Direct company coverage

Canaccord Genuity Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)

Canaccord Genuity analyst Kyle Mikson CFA reiterated a Buy rating on Tempus AI, Inc. Class A (TEM) with a price target of $80.00. This comes as Tempus AI reported a quarterly revenue of $348.12 million for the quarter ending March 31, despite a GAAP net loss of $125.92 million. O

Tone
Positive 76/100
Event
Analyst action
Published
03 Jun 2026 11:40
Source
The Globe and Mail